| aHUS | Atypical hemolytic uremic syndrome |
| ABMR | Antibody-mediated rejection |
| AKI | Acute kidney injury |
| CRRT | Continuous renal replacement therapy |
| TMA | Thrombotic microangiopathy |
| MP | Methylprednisolone |
| MMF | Mycophenolate mofetil |
| AZA | Azathioprine |
| aHUS | Atypical hemolytic uremic syndrome |
| ABMR | Antibody-mediated rejection |
| AKI | Acute kidney injury |
| CRRT | Continuous renal replacement therapy |
| TMA | Thrombotic microangiopathy |
| MP | Methylprednisolone |
| MMF | Mycophenolate mofetil |
| AZA | Azathioprine |